The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy
Clinical trial NCT02024191 · UNKNOWN
Trial details
- NCT number
- NCT02024191
- Sponsor
- Ankara Education and Research Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.